Trials / Completed
CompletedNCT00460785
Bioequivalence Trial of a New Opioid Combination Compared to Reference
Phase 1 Single Center Trial to Demonstrate the Bioequivalence of a New Combination Analgesic Formulation as Compared to an Equimolar Marketed Formulation
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (planned)
- Sponsor
- Grünenthal GmbH · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate bioequivalence of a new formulation to a reference
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Opioid |
Timeline
- Start date
- 2007-02-01
- Completion
- 2007-03-01
- First posted
- 2007-04-16
- Last updated
- 2007-07-06
Source: ClinicalTrials.gov record NCT00460785. Inclusion in this directory is not an endorsement.